NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $76.14 +0.17 (+0.22%) As of 02:29 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Solventum Stock (NYSE:SOLV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Solventum alerts:Sign Up Key Stats Today's Range$74.33▼$76.3150-Day Range$62.49▼$76.9252-Week Range$62.38▼$88.20Volume2.35 million shsAverage Volume2.26 million shsMarket Capitalization$13.18 billionP/E Ratio9.30Dividend YieldN/APrice Target$84.25Consensus RatingModerate Buy Company Overview Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota. Read More Solventum Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreSOLV MarketRank™: Solventum scored higher than 63% of companies evaluated by MarketBeat, and ranked 360th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingModerate Buy Consensus RatingSolventum has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 8 buy ratings, 5 hold ratings, and 1 sell rating.Upside PotentialSolventum has a consensus price target of $84.25, representing about 10.7% upside from its current price of $76.09.Amount of Analyst CoverageSolventum has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth7.29% Earnings GrowthEarnings for Solventum are expected to grow by 7.29% in the coming year, from $6.58 to $7.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Solventum is 9.30, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.29.Price to Earnings Ratio vs. SectorThe P/E ratio of Solventum is 9.30, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 21.14.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.16. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSolventum has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Solventum's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted4.57% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 4.11.Change versus previous monthShort interest in Solventum has recently increased by 21.73%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. News and Social Media2.1 / 5News Sentiment0.30 News SentimentSolventum has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Solventum this week, compared to 5 articles on an average week.Search InterestOnly 7 people have searched for SOLV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows4 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,344.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.24% of the stock of Solventum is held by insiders.Percentage Held by InstitutionsSolventum has minimal institutional ownership at this time.Read more about Solventum's insider trading history. Receive SOLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SOLV Stock News HeadlinesExecutives at Solventum commute to Minnesota by plane. A shareholder wants to change thatMay 30 at 1:51 PM | msn.comCritical Review: Concentra Group Holdings Parent (NYSE:CON) versus Solventum (NYSE:SOLV)May 28, 2026 | americanbankingnews.comA gold storm is coming – are you ready?The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following suit ahead of what could be a massive market shift. But they're not buying bullion or coins. They're loading up on a niche asset with far more upside potential - and the details are available right now.June 2 at 1:00 AM | Traders Agency (Ad)Solventum Adopts Updated Executive Severance and Compensation PlanMay 27, 2026 | tipranks.comSolventum to Participate in the 2026 Jefferies Healthcare ConferenceMay 27, 2026 | prnewswire.comSolventum Corporation (NYSE:SOLV) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMay 25, 2026 | americanbankingnews.comSolventum Shareholders Back Board, Pay and Auditor ChoicesMay 20, 2026 | tipranks.comTarget the Red-Hot Spin-Off and Merger Space With These ETFs (SOLV)Spin-offs and mergers can lead to major movement for share prices, but accessing these scenarios can be challenging for investors; these ETFs can help.May 16, 2026 | marketbeat.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $79.25 on January 1st, 2026. Since then, SOLV shares have decreased by 4.0% and is now trading at $76.0910. How were Solventum's earnings last quarter? Solventum Corporation (NYSE:SOLV) released its quarterly earnings results on Tuesday, May, 5th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.35 by $0.13. The company's revenue was down 3.0% compared to the same quarter last year. Read the conference call transcript. How will Solventum's stock buyback program work? Solventum's Board of Directors initiated a share buyback plan on Thursday, November 20th 2025, which permits the company to buy back $1,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 7.5% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's leadership believes its stock is undervalued. Who are Solventum's major shareholders? Solventum's top institutional shareholders include Bank of America Corp DE (0.83%), Arrowstreet Capital Limited Partnership (0.51%), Bank of New York Mellon Corp (0.45%) and Dimensional Fund Advisors LP (0.45%). View institutional ownership trends. How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Solventum own? Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AUO (AUOTY). Company Calendar Last Earnings5/05/2026Today6/02/2026Jefferies Global Healthcare Conference 20266/03/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 SOLV's financial health is in the Red zone, according to TradeSmith. SOLV has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous SymbolNYSE:SOLV CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees20,000Year Founded2023Price Target and Rating Average Price Target for Solventum$84.25 High Price Target$103.00 Low Price Target$50.00 Potential Upside/Downside+10.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage14 Analysts Profitability EPS (Trailing Twelve Months)$8.16 Trailing P/E Ratio9.30 Forward P/E Ratio11.57 P/E Growth1.16Net Income$1.56 billion Net Margins17.33% Pretax Margin20.47% Return on Equity23.51% Return on Assets7.63% Debt Debt-to-Equity Ratio0.96 Current Ratio1.07 Quick Ratio0.75 Sales & Book Value Annual Sales$8.26 billion Price / Sales1.60 Cash Flow$9.13 per share Price / Cash Flow8.34 Book Value$29.11 per share Price / Book2.62Miscellaneous Outstanding Shares173,175,000Free Float172,759,000Market Cap$13.18 billion OptionableOptionable Beta0.59 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:SOLV) was last updated on 6/2/2026 by MarketBeat.com Staff. From Our PartnersThe Rare Earth Shift Few Saw ComingRare earth elements sit inside modern defense systems, high-performance magnets, and advanced electronics - ye...i2i Marketing Group, LLC | SponsoredHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredBNZI posted 169 percent revenue growth - is a turnaround formingBanzai International (NASDAQ: BNZI) reported full-year 2025 revenue of $12.2 million, up 169% year-over-year, ...Huge Alerts | SponsoredA gold storm is coming – are you ready?The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following s...Traders Agency | SponsoredFree: The Crypto Summit That Could Change Your LifeWe have assembled 27 of the top crypto experts in the world. Multi-millionaires, fund managers, coin creato...Crypto 101 Media | SponsoredGiving “2022 pre-ChatGPT” vibes (but 10x bigger)When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...StocksToTrade | Sponsored"You'll own nothing and be happy" (it's not a theory anymore)Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solventum Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SOLV Stock Alerts